End-of-day quote
Shanghai S.E.
06:00:00 2024-07-04 pm EDT
|
5-day change
|
1st Jan Change
|
16.78
CNY
|
+1.51%
|
|
-1.24%
|
-18.23%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
6,990
|
11,957
|
6,909
|
8,300
|
6,788
|
-
|
Enterprise Value (EV)
1 |
6,990
|
11,957
|
6,909
|
8,300
|
6,788
|
6,788
|
P/E ratio
|
25
x
|
37.9
x
|
19
x
|
20.3
x
|
-
|
-
|
Yield
|
-
|
1.18%
|
2.34%
|
2.19%
|
-
|
-
|
Capitalization / Revenue
|
-
|
3.51
x
|
1.82
x
|
1.99
x
|
1.26
x
|
1.07
x
|
EV / Revenue
|
-
|
3.51
x
|
1.82
x
|
1.99
x
|
1.26
x
|
1.07
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-312,967,081
x
|
13,192,483
x
|
52,865,374
x
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
0%
|
0%
|
-
|
-
|
Price to Book
|
-
|
4.89
x
|
2.6
x
|
2.85
x
|
-
|
-
|
Nbr of stocks (in thousands)
|
404,500
|
404,500
|
404,500
|
404,500
|
404,500
|
-
|
Reference price
2 |
17.28
|
29.56
|
17.08
|
20.52
|
16.78
|
16.78
|
Announcement Date
|
2/26/21
|
2/23/22
|
2/7/23
|
1/26/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
-
|
3,407
|
3,795
|
4,173
|
5,381
|
6,325
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
346.3
|
380.5
|
454.3
|
-
|
665
|
Operating Margin
|
-
|
10.16%
|
10.03%
|
10.89%
|
-
|
10.51%
|
Earnings before Tax (EBT)
|
-
|
351.9
|
382.1
|
453.9
|
-
|
668
|
Net income
1 |
281
|
315.1
|
363.3
|
410.1
|
518
|
625
|
Net margin
|
-
|
9.25%
|
9.57%
|
9.83%
|
9.63%
|
9.88%
|
EPS
|
0.6900
|
0.7800
|
0.9000
|
1.010
|
-
|
-
|
Free Cash Flow
|
-
|
-38.21
|
523.7
|
157
|
-
|
-
|
FCF margin
|
-
|
-1.12%
|
13.8%
|
3.76%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
144.14%
|
38.29%
|
-
|
-
|
Dividend per Share
|
-
|
0.3500
|
0.4000
|
0.4500
|
-
|
-
|
Announcement Date
|
2/26/21
|
2/23/22
|
2/7/23
|
1/26/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-38.2
|
524
|
157
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
13.3%
|
14.3%
|
14.8%
|
-
|
16.2%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
-
|
6.040
|
6.580
|
7.210
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
146
|
182
|
243
|
-
|
-
|
Capex / Sales
|
-
|
4.29%
|
4.79%
|
5.82%
|
-
|
-
|
Announcement Date
|
2/26/21
|
2/23/22
|
2/7/23
|
1/26/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -18.23% | 920M | | 0.00% | 8.6B | | -20.56% | 2.4B | | -26.11% | 2.25B | | -26.80% | 1.82B | | +14.78% | 961M | | -20.85% | 932M | | -2.28% | 709M | | -31.19% | 636M | | -4.73% | 529M |
Testing Laboratories
|